Westwood Bioscience is Drug Delivery in United States that focus on colon cancer business. Founded in 2017. They cover business area such as developer, silicasome nano-particle technology, improved delivery, chemotherapeutic agent, pancrea, colon cancer, their toxicity, use, nanocarrier, drug delivery, biodistribution, tissue concentration, efficacy, potentially hazardous drug, oncologist, cancer patient, chemotherapy.
2017
( 7 years old in 2024 )
Colon Cancer
-
12100 Wilshire Boulevard
Suite 800
Los Angeles, CA 90025
United States
Private
developersilicasome nano-particle technologyimproved deliverychemotherapeutic agentpancreacolon cancertheir toxicityusenanocarrierdrug deliverybiodistributiontissue concentrationefficacypotentially hazardous drugoncologistcancer patientchemotherapy
* We use standard office opening hours in near Westwood Bioscience's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Westwood Bioscience is Drug Delivery business from United States that founded in 2017 (7 years old in 2024), Westwood Bioscience business is focusing on Colon Cancer.
Westwood Bioscience headquarter office and corporate office address is located in 12100 Wilshire Boulevard Suite 800 Los Angeles, CA 90025 United States.
Westwood Bioscience was founded in United States.
In 2024, Westwood Bioscience is currently focus on colon cancer sector.
Above is snippet of Google Trends for "colon cancer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Westwood Bioscience, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
